Related references
Note: Only part of the references are listed.Energy Management by Enhanced Glycolysis in G1-phase in Human Colon Cancer Cells In Vitro and In Vivo
Yan Bao et al.
MOLECULAR CANCER RESEARCH (2013)
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Peppi Koivunen et al.
NATURE (2012)
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Gregg L. Semenza
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels
Hiroshi Harada et al.
NATURE COMMUNICATIONS (2012)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
PrognoScan: a new database for meta-analysis of the prognostic value of genes
Hideaki Mizuno et al.
BMC MEDICAL GENOMICS (2009)
Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy
H. Harada et al.
BRITISH JOURNAL OF CANCER (2009)
The intravenous anesthetics barbiturates inhibit hypoxia-inducible factor 1 activation
Takuhiko Wakamatsu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors
Hiroshi Harada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis
Shuta Tomida et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Gregg L. Semenza
SEMINARS IN CANCER BIOLOGY (2009)
TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis
Lihua Zeng et al.
CANCER SCIENCE (2008)
Significance of HIF-1-active cells in angiogenesis and radioresistance
H. Harada et al.
ONCOGENE (2007)
The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts
Hiroshi Harada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2007)
Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry
Sunil U. Bajad et al.
JOURNAL OF CHROMATOGRAPHY A (2006)
Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases
K Hirota et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan et al.
BREAST CANCER RESEARCH (2005)
FIH-1:: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
PC Mahon et al.
GENES & DEVELOPMENT (2001)
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
E Laughner et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Share Paper
